好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Immune-Cell Phenotypes after Prolonged Natalizumab Treatment as Possible Markers of Sustained Response to Therapy
MS and Related Diseases
(-)
243
Authors/Disclosures
Styliani (. Marousi No disclosure on file
Ioannis Karkanis (Gennimatas General Hospital of Athens) No disclosure on file
Themistokles Kalamatas (General Anthens Hospital) No disclosure on file
David S. Goldstein, MD, PhD (National Institutes of Health) Dr. Goldstein has received publishing royalties from a publication relating to health care.
Giorgos Tagaris No disclosure on file
No disclosure on file
Clementine Karageorgiou, MD (Neurological Institute of Athens) The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.